Joseph J. Wolk net worth and biography

Joseph Wolk Biography and Net Worth

Joseph J. Wolk (Joe) is the Executive Vice President and Chief Financial Officer for Johnson & Johnson. Joe serves as a member of company’s Executive Committee, playing a strategic role in the overall management of the organization and leading the development and execution of the business’ global long-term financial strategy. Additionally, as the financial steward of Johnson & Johnson, Joe’s scope of responsibilities includes driving competitive and profitable growth, generating sustainable cash flow, allocating capital to maximize value creation and managing risk across the entire enterprise.

Joe leads the worldwide Finance and Global Services organizations, which includes approximately 9,000 colleagues around the globe. He has been with Johnson & Johnson for 24 years, assuming the role of Chief Financial Officer in 2018.

Prior to assuming his current responsibilities, Joe was the Vice President of Investor Relations for Johnson & Johnson. In this role, he developed a winning strategy for building strong relationships with the investment community and disseminating Johnson & Johnson’s value creation narrative to all external financial stakeholders. During Joe’s tenure in this role, the Investor Relations function was regularly recognized by Institutional Investor as one of the best teams in the industry.

Prior to Investor Relations, Joe held a variety of senior leadership roles in several sectors and functions across the company, where he achieved superior results. He served as Vice President of Finance for the Pharmaceuticals Group, Vice President of Finance for the Medical Devices Global Supply Chain and Chief Financial Officer of the North America Pharmaceuticals Group.

Joe is an accomplished, Credo-based leader; passionate about talent development, driving innovation, and community service. He is the executive sponsor of Johnson & Johnson’s Impact Venture Fund, an “impact investment” fund that provides funding to entrepreneurs and their start-up companies or social enterprises to address healthcare challenges impacting people around the world. He is also the executive sponsor of the Veterans Leadership Council and a champion of the Finance Leadership Development Program. Additionally, he is a member of the Stanford Medicine Board of Fellows, the CNBC Global CFO Council and the Wall Street Journal CFO Network.

Joe holds a Bachelor of Science degree in Finance from St. Joseph’s University, where he serves on the University’s Board of Trustees and was recently inducted into the University’s Haub School of Business Hall of Fame for his excellence in business management. He earned his Juris Doctor degree from Temple University School of Law and is also a Certified Public Accountant (CPA).

What is Joseph J. Wolk's net worth?

The estimated net worth of Joseph J. Wolk is at least $5.90 million as of December 13th, 2022. Mr. Wolk owns 35,812 shares of Johnson & Johnson stock worth more than $5,895,013 as of February 5th. This net worth evaluation does not reflect any other assets that Mr. Wolk may own. Learn More about Joseph J. Wolk's net worth.

What is Joseph J. Wolk's salary?

As the CFO of Johnson & Johnson, Mr. Wolk earned a total compensation package of $10,953,615.00 in 2021. Mr. Wolk earned a salary of $938,077.00, stock awards of $4,877,538.00, options awards of $1,688,997.00, non-equity compensation of $1,560,863.00, and other compensation of $78,243.00. Learn More on Joseph J. Wolk's salary.

How do I contact Joseph J. Wolk?

The corporate mailing address for Mr. Wolk and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400. Learn More on Joseph J. Wolk's contact information.

Has Joseph J. Wolk been buying or selling shares of Johnson & Johnson?

Joseph J. Wolk has not been actively trading shares of Johnson & Johnson during the last ninety days. Most recently, Joseph J. Wolk sold 14,781 shares of the business's stock in a transaction on Tuesday, December 13th. The shares were sold at an average price of $179.60, for a transaction totalling $2,654,667.60. Following the completion of the sale, the chief financial officer now directly owns 35,812 shares of the company's stock, valued at $6,431,835.20. Learn More on Joseph J. Wolk's trading history.

Who are Johnson & Johnson's active insiders?

Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Director ), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Michael Sneed (COO), Paulus Stoffels (VP), Jennifer Taubert (EVP), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.

Are insiders buying or selling shares of Johnson & Johnson?

During the last year, insiders at the sold shares 13 times. They sold a total of 402,592 shares worth more than $70,380,755.50. The most recent insider tranaction occured on December, 13th when CFO Joseph J Wolk sold 14,781 shares worth more than $2,654,667.60. Insiders at Johnson & Johnson own 0.4% of the company. Learn More about insider trades at Johnson & Johnson.

Information on this page was last updated on 12/13/2022.

Joseph J. Wolk Insider Trading History at Johnson & Johnson

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2022Sell14,781$179.60$2,654,667.6035,812View SEC Filing Icon  
See Full Table

Joseph J. Wolk Buying and Selling Activity at Johnson & Johnson

This chart shows Joseph J Wolk's buying and selling at Johnson & Johnson by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Johnson & Johnson Company Overview

Johnson & Johnson logo
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Read More

Today's Range

Now: $164.61
Low: $163.89
High: $166.34

50 Day Range

MA: $174.35
Low: $162.00
High: $180.25

2 Week Range

Now: $164.61
Low: $155.72
High: $186.69


6,868,540 shs

Average Volume

7,904,965 shs

Market Capitalization

$430.37 billion

P/E Ratio


Dividend Yield